S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Siemens Healthineers (SHL) Stock Forecast, Price & News

-1.18 (-2.12%)
(As of 05/19/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
615,370 shs
Average Volume
Market Capitalization
$61.21 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SHL News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

Siemens Healthineers logo

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.


See More Headlines

Industry, Sector and Symbol

Diagnostics & Research
Year Founded

Sales & Book Value

Annual Sales
$20.69 billion
Cash Flow
€0.97 per share
Book Value
€15.19 per share


Pretax Margin




Outstanding Shares
Free Float
Market Cap
$61.21 billion
Not Optionable

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.46 out of 5 stars

Analyst Opinion: 2.3Community Rank: 3.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Siemens Healthineers (ETR:SHL) Frequently Asked Questions

Is Siemens Healthineers a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Siemens Healthineers stock.
View analyst ratings for Siemens Healthineers
or view top-rated stocks.

When is Siemens Healthineers' next earnings date?

Siemens Healthineers is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022.
View our earnings forecast for Siemens Healthineers

Is Siemens Healthineers a good dividend stock?

Siemens Healthineers pays an annual dividend of €0.85 per share and currently has a dividend yield of 1.53%. The dividend payout ratio of Siemens Healthineers is 50.27%. This payout ratio is at a healthy, sustainable level, below 75%.

What price target have analysts set for SHL?

5 Wall Street analysts have issued 1 year price objectives for Siemens Healthineers' stock. Their forecasts range from €46.40 to €75.00. On average, they expect Siemens Healthineers' stock price to reach €67.04 in the next year. This suggests a possible upside of 23.0% from the stock's current price.
View analysts' price targets for Siemens Healthineers
or view top-rated stocks among Wall Street analysts.

Who are Siemens Healthineers' key executives?
Siemens Healthineers' management team includes the following people:
  • Dr. Bernhard Montag, Pres, CEO & Chairman of Management Board (Age 53, Pay $2.88M)
  • Dr. Jochen Schmitz, CFO & Member of Management Board (Age 56, Pay $1.86M)
  • Ms. Darleen Caron, Chief HR Officer & Member of Management Board (Age 58, Pay $1.37M)
  • Ms. Elisabeth Staudinger, Member of Management Board & Head of Asia Pacific (Age 52)
  • Mr. Marc Koebernick, Head of Investor Relations
  • Mr. Michel Therin, Pres of Advanced Therapies (Age 61)
  • Martin Fischer, Head of Fin. Diagnostics
  • Christian Klaussner, Exec. VP of Fin.
  • Andre Hartung, Head of Imaging
  • Mr. Christopher A. Toth, Head of Varian (Age 43)
What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), (PHIA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT).

What is Siemens Healthineers' stock symbol?

Siemens Healthineers trades on the ETR under the ticker symbol "SHL."

What is Siemens Healthineers' stock price today?

One share of SHL stock can currently be purchased for approximately €54.52.

How much money does Siemens Healthineers make?

Siemens Healthineers has a market capitalization of $61.21 billion and generates $20.69 billion in revenue each year.

How many employees does Siemens Healthineers have?

Siemens Healthineers employs 66,800 workers across the globe.

What is Siemens Healthineers' official website?

The official website for Siemens Healthineers is www.healthcare.siemens.de.

How can I contact Siemens Healthineers?

The company can be reached via phone at 49 69 6682 6602.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.